Murine models of hemoglobinopathies
Beuzard, Y.
Pathologie-Biologie 46(2): 118-119
1998
ISSN/ISBN: 0369-8114 PMID: 9769925 Document Number: 484532
Document emailed within 1 workday
Related Documents
Hellström, I.; Hellström, K.E. 1972: Murine bladder tumors as models for human tumor immunity National Cancer Institute Monograph 35: 125-127Kotzin, B.L.; Lafferty, J.A.; Portanova, J.P.; Rubin, R.L.; Tan, E.M. 1984: Monoclonal anti-histone autoantibodies derived from murine models of lupus Journal of Immunology 133(5): 2554-2559
Maruyama, M. 1992: A morphological study of pulmonary macrophages in bleomycin-injected murine models Nihon Kyobu Shikkan Gakkai Zasshi 30(3): 384-392
Dighiero, G. 1987: Relevance of murine models in elucidating the origin of B-CLL lymphocytes and related immune-associated phenomena Seminars in Hematology 24(4): 240-251
Heimesaat, M.M.; Bereswill, S. 2015: Murine infection models for the investigation of Campylobacter jejuni--host interactions and pathogenicity Berliner und Munchener Tierarztliche Wochenschrift 128(3-4): 98-103
Brennan, M.J. 1976: Murine and rat mammary tumors as models for the immunological study of human breast cancer Cancer Research 36(2 Part 2): 728-733
Evans, G.F.; Snyder, Y.M.; Butler, L.D.; Zuckerman, S.H. 1989: Differential expression of interleukin-1 and tumor necrosis factor in murine septic shock models Circulatory Shock 29(4): 279-290
Zhang, H.; Zhang, P.; Han, C.; Zhou, F.; Li, L.; Liu, W. 2016: Treatment of hyperoxic acute lung injury with stem cell transplantation in murine models: a brief review Undersea and Hyperbaric Medicine: Journal of the Undersea and Hyperbaric Medical Society Inc 43(4): 437-445
Reipert, B.M.; Schoppmann, A.; Schwarz, H.Peter. 2003: A caution on the use of murine hemophilia models for comparative immunogenicity studies of FVIII products with different protein compositions Thrombosis and haemostasis 89(6): 1110-2; author reply 1113
Gutsche, W.; Schulze, W.; Jungstand, W.; Wohlrabe, K. 1983: Antineoplastic and curative antileukemic activity of 1,4-benzoquinone guanylhydrazone thiosemicarbazone and its hydrochloride on in vivo murine models Die Pharmazie 38(2): 105-107
Iakovleva, O.N.; Lycheva, T.A.; Petrovskaia, V.G. 1982: Comparative study of Salmonella typhimurium strains of various origins in murine models of enteral and intranasal infection Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 9: 53-57
Dabrowska, K.; Opolski, A.; Wietrzyk, J.; Switala-Jelen, K.; Boratynski, J.; Nasulewicz, A.; Lipinska, L.; Chybicka, A.; Kujawa, M.; Zabel, M.; Dolinska-Krajewska, B.; Piasecki, E.; Weber-Dabrowska, B.; Rybka, J.; Salwa, J.; Wojdat, E.; Nowaczyk, M.; Gorski, A. 2004: Antitumor activity of bacteriophages in murine experimental cancer models caused possibly by inhibition of beta3 integrin signaling pathway Acta Virologica 48(4): 241-248
Mirabelli, C.K.; Johnson, R.K.; Sung, C.M.; Faucette, L.; Muirhead, K.; Crooke, S.T. 1985: Evaluation of the in vivo antitumor activity and in vitro cytotoxic properties of auranofin, a coordinated gold compound, in murine tumor models Cancer Research 45(1): 32-39
Del Amparo, R.; Arenas, M. 2021: HIV Protease and Integrase Empirical Substitution Models of Evolution: Protein-Specific Models Outperform Generalist Models Genes 13(1)
Winkelhake, J.L.; Stampfl, S.; Zimmerman, R.J. 1987: Synergistic effects of combination therapy with human recombinant interleukin-2 and tumor necrosis factor in murine tumor models Cancer Research 47(15): 3948-3953
Farzana, F. 1975: Hemoglobinopathies JPMA. Journal of the Pakistan Medical Association 25(5): 103-107
Duffy, T.P. 1974: The kidney in hemoglobinopathies Birth Defects Original Article Series 10(4): 60-61
Huntsman, R.G. 1978: Hemoglobinopathies: how big a problem? Canadian Medical Association Journal 119(7): 675-679
Oort, M.; Roos, D. 1982: Hemoglobinopathies and thalassemias Nederlands Tijdschrift Voor Geneeskunde 126(27): 1234-1237
De Montalembert, M. 1997: New treatments of hemoglobinopathies Presse Medicale 26(20): 972-976